3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase NA
3
Phase 3
3
Phase 4
1
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
104
Carcinoma, Hepatocellular
103
Stomach Neoplasms
62
Pancreatic Neoplasms
46
Liver Neoplasms
38
Colonic Neoplasms
37
Esophageal Neoplasms
28
Rectal Neoplasms
22
Neoplasms
13
Neoplasm Metastasis
13
Gastrointestinal Neoplasms
12
Barrett Esophagus
11
Recurrence
10
Gastrointestinal Stromal Tumors
10
Breast Neoplasms
10
Bile Duct Neoplasms
10
Pain, Postoperative
9
Lung Neoplasms
8
Cholangiocarcinoma
8
Head and Neck Neoplasms
7
Malnutrition
6
Hepatitis B
6
Carcinoma, Non-Small-Cell Lung
6
Biliary Tract Neoplasms
6
Agnosia
6
Adenocarcinoma
6
Prostatic Neoplasms
5
Postoperative Complications
5
Peptic Ulcer
5
Pain
5
Interventions
Telbivudine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Drug-Related Side Effects and Adverse Reactions
×
Gastrointestinal
×
Clear all
NCT01102335
2010-04-13
TACEHBV
Fudan University
Phase 4
Unknown
80 enrolled